G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2627535
The present invention provides a method for predicting whether an individual (e.g., patient) will benefit from a (one or more) treatment for cancer comprising determining the amount of p66-Shc present in cancerous cells or precancerous cells (e.g., displasia) of the individual. If the amount of p66- Shc present in the cells of the individual is lower than the amount of p66-Shc in a control, then the individual will likely benefit from the treatment.
La présente invention concerne un procédé pour prévoir si une personne (par exemple le patient) bénéficiera d'un (ou de plusieurs) traitement du cancer comprenant la détermination du nombre de p66-Shc présents dans les cellules cancéreuses ou précancéreuses (par exemple dysplasie) de la personne. Si la quantité de p66-Shc présents dans les cellules de la personne est inférieure à la quantité de p66-Shc dans un contrôle, la personne bénéficiera alors probablement du traitement.
Gowling Lafleur Henderson Llp
Roger Williams Hospital
LandOfFree
P66-shc as predictive marker in cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P66-shc as predictive marker in cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P66-shc as predictive marker in cancer treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1853633